对比康柏西普与雷珠单抗玻璃体腔注射治疗视网膜分支静脉阻塞继发黄斑水肿的疗效OACSTPCD
Efficacy of conbercept versus ranibizumab for macular edema secondary to branch retinal vein occlusion
目的 对比康柏西普与雷珠单抗玻璃体腔注射治疗视网膜分支静脉阻塞(BRVO)继发黄斑水肿的疗效,探讨视网膜各层次厚度与视力的关系.方法 回顾性病例研究.纳入我院就诊并通过临床检查确诊为BR-VO继发黄斑水肿的患者30例(30只眼),分别为康柏西普治疗组(A组)16只眼、雷珠单抗治疗组(B组)14只眼.两组患眼分别行0.05 ml康柏西普或0.05 ml雷珠单抗玻璃体腔注射,于注射前和注射后1、2、3个月进行复查.主要评价指标包括注射眼最佳矫正视力(…查看全部>>
Objective To compare the efficacy of conbercept and ranibizumab intravitreal injection for the treat -ment of macular edema(ME)second to branch retinal vein occlusion(BRVO)and investigate the relationship between the retinal thickness and visual acuity.Methods A retrospective study including thirty eyes of 30 patients with macular edema in BRVO.16 eyes were treated with conbercept(group A)and 14 with ranibizumab(group B).Intravitreal injection of 0.05 ml con…查看全部>>
严欢;龚立艳;李立
400010 重庆医科大学附属第二医院400010 重庆医科大学附属第二医院400010 重庆医科大学附属第二医院
视网膜静脉阻塞黄斑水肿血管生成抑制剂相干光断层扫描
Retinal vein occlusionDrug therapyMacular edemaAngiogenesis inhibitorsOptical coherence tomographyComparative studies
《临床眼科杂志》 2018 (1)
5-9,5
评论